L26/P-619 Prospective cohort study of endometrial fluid miRNAs as epigenetic mediators and biomarkers of offspring obesity risk
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.949 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Monteagudo-Sanchez und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Are endometrial fluid miRNA profiles during the window of implantation associated with maternal obesity and offspring obesity risk, and which miRNAs are involved? Summary answer Endometrial miRNAs (miR-144-3p, miR-486-5p, miR-4516, miR-10400-5p, miR-379) associated with maternal/offspring obesity, implicating insulin/mTOR pathways, genomic imprinting, early developmental programming during implantation window, suggesting preconception biomarkers. What is known already Maternal obesity increases offspring obesity and cardiometabolic risk, yet clinically actionable preconception biomarkers in humans are lacking. During the window of implantation, the endometrium secretes small RNAs into endometrial fluid, which can be internalized by the pre-implantation embryo and influence early transcriptional and epigenetic programmes. Defining obesity associated endometrial miRNA signatures may therefore provide a biologically grounded approach to identify women at increased intergenerational metabolic risk and to inform counselling and intervention strategies in assisted reproduction. Study design, size, duration Prospective observational cohort study. Endometrial fluid was collected during the window of implantation (cycle days 19–23) from 80 women stratified by maternal BMI and offspring weight status into four groups (n = 20/group). Offspring obesity was defined using WHO BMI-for-age z-scores (obesity: > +3 SD if < 5 years; > +2 SD if ≥ 5 years). Participants/materials, setting, methods Normal-weight and obese women (BMI 30–<40 kg/m²) were recruited at Hospital La Fe (Valencia, Spain). Endometrial fluid was aspirated during the window of implantation. miRNA libraries (Lexogen) were sequenced on Illumina NovaSeq 6000 (single-end 50 bp; ∼15M reads/sample). After QC and miRBase alignment, differential expression used DESeq2 with Benjamini–Hochberg FDR, adjusting for sample-year batch; group definitions were prespecified. Clinical covariates (age, parity and smoking) were comparable. Targets/pathways were explored with multiMiR. Main results and the role of chance Endometrial miRNAs were robustly and reproducibly detected across analyzed samples, including highly abundant species such as miR-10a-5p and miR-10b-5p. A likelihood ratio test across the four maternal/offspring BMI groups indicated that the main signal was driven by obese mothers with obese offspring, relative to the other groups (normal-weight mothers with obese or normal-weight offspring, and obese mothers with normal-weight offspring). In this comparison, five miRNAs remained significant after Benjamini–Hochberg FDR correction: miR-144-3p (adjusted p = 0.011), miR-486-5p (adjusted p = 0.035), miR-4516 (adjusted p = 0.035), miR-10400-5p (adjusted p = 0.048) and miR-379 (adjusted p = 0.038). Exploratory target analysis linked miR-144-3p to insulin and growth signaling pathways, including insulin receptor substrate 1 (IRS1), transforming growth factor beta 1 (TGFB1) and mechanistic target of rapamycin (mTOR), pathways relevant to endometrial function and metabolic programming. Notably, miR-379 belongs to the imprinted miR-379/miR-410 cluster, is expressed from the maternal allele, and is normally regulated by differentially methylated regions. Experimental models demonstrate severe developmental consequences of dysregulation at this locus, and human studies link altered methylation to maternal glycaemic status. These findings support the concept that endometrial miRNA signals present at implantation support a potential role as early biomarkers and mediators of intergenerational metabolic risk. Limitations, reasons for caution Directionality, confounding factors and predictive performance will be evaluated in the full cohort. Functional validation of embryo uptake and causal effects is required before clinical application. Wider implications of the findings Endometrial fluid miRNA profiling during the window of implantation could represent a minimally invasive tool to support preconception risk stratification, inform ART counselling in women with obesity, and guide targeted metabolic optimisation strategies before embryo transfer. *AM and FB contributed equally. Supported by European Union’s Horizon Europe programme (eprObes;Project ID 101080219; HORIZON-HLTH-2022-STAYHLTH-01-01). Trial registration number No
Zitieren
APA
Monteagudo-Sanchez, A., Barbera, F., Monfort, R., Quirant, A., Amoros, D., Simon, C., & Vilella, F. (2026). L26/P-619 Prospective cohort study of endometrial fluid miRNAs as epigenetic mediators and biomarkers of offspring obesity risk. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.949
Vancouver
Monteagudo-Sanchez A, Barbera F, Monfort R, Quirant A, Amoros D, Simon C, et al. L26/P-619 Prospective cohort study of endometrial fluid miRNAs as epigenetic mediators and biomarkers of offspring obesity risk. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.949
BibTeX
@article{MonteagudoSanchez2026,
author = {Monteagudo-Sanchez, A. and Barbera, F. and Monfort, R. and Quirant, A. and Amoros, D. and Simon, C. and Vilella, F.},
title = {L26/P-619 Prospective cohort study of endometrial fluid miRNAs as epigenetic mediators and biomarkers of offspring obesity risk},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.949}
}
EUVIMED